Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors

BACKGROUND: Approximately 40–50% of patients with pancreatic neuroendocrine tumors (pNETs) initially present with distant metastases. Little is known about the outcomes of patients undergoing combined pancreatic and hepatic resections for this indication. METHODS: Patients who underwent hepatectomy...

Descripción completa

Detalles Bibliográficos
Autores principales: Gudmundsdottir, Hallbera, Pery, Ron, Graham, Rondell P., Thiels, Cornelius A., Warner, Susanne G., Smoot, Rory L., Truty, Mark J., Kendrick, Michael L., Halfdanarson, Thorvardur R., Habermann, Elizabeth B., Nagorney, David M., Cleary, Sean P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Endocrine Tumors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492589/
https://www.ncbi.nlm.nih.gov/pubmed/35731358
http://dx.doi.org/10.1245/s10434-022-12029-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492589/
https://www.ncbi.nlm.nih.gov/pubmed/35731358
http://dx.doi.org/10.1245/s10434-022-12029-7

Ejemplares similares